Advances in our understanding of cancer immunology and the mechanisms by which cancer immunotherapies exert their effects have translated into increasingly positive patient outcomes.
The recent successes of immunotherapeutics, particularly immune checkpoint inhibitors, have served to demonstrate the power and potential of immune-based treatment strategies. Now there is a need to build upon what we have learned in order to effectively treat more patients with cancer.
Cancer Immunotherapy CONNECT, powered by SITC is your hub for live and online educational opportunities. This website provides access to all of the latest data in the field of tumor immunology and cancer immunotherapy. Connect to other researchers in our online Community and submit your manuscript to JITC to help drive progress.